SK287298B6 - Tuhý perorálny farmaceutický prostriedok vo forme tabliet s obsahom derivátu kyseliny bifosfónovej substituovaného aminoskupinami a spôsob jeho výroby - Google Patents

Tuhý perorálny farmaceutický prostriedok vo forme tabliet s obsahom derivátu kyseliny bifosfónovej substituovaného aminoskupinami a spôsob jeho výroby Download PDF

Info

Publication number
SK287298B6
SK287298B6 SK1584-2002A SK15842002A SK287298B6 SK 287298 B6 SK287298 B6 SK 287298B6 SK 15842002 A SK15842002 A SK 15842002A SK 287298 B6 SK287298 B6 SK 287298B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
cores
derivative
acid
solid oral
Prior art date
Application number
SK1584-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK15842002A3 (sk
Inventor
Stanislaw Adamski
Andrzej Zaremba
Wieslaw Szelejewski
Zofia Marchlewska-Cela
Katarzyna Berkan
Original Assignee
Instytut Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Farmaceutyczny filed Critical Instytut Farmaceutyczny
Publication of SK15842002A3 publication Critical patent/SK15842002A3/sk
Publication of SK287298B6 publication Critical patent/SK287298B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1584-2002A 2000-05-11 2001-05-10 Tuhý perorálny farmaceutický prostriedok vo forme tabliet s obsahom derivátu kyseliny bifosfónovej substituovaného aminoskupinami a spôsob jeho výroby SK287298B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL340087A PL196485B1 (pl) 2000-05-11 2000-05-11 Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania
PCT/PL2001/000039 WO2001085176A1 (en) 2000-05-11 2001-05-10 The solid oral pharmaceutical composition comprising a bisphosphonic acid derivative

Publications (2)

Publication Number Publication Date
SK15842002A3 SK15842002A3 (sk) 2003-03-04
SK287298B6 true SK287298B6 (sk) 2010-06-07

Family

ID=20076600

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1584-2002A SK287298B6 (sk) 2000-05-11 2001-05-10 Tuhý perorálny farmaceutický prostriedok vo forme tabliet s obsahom derivátu kyseliny bifosfónovej substituovaného aminoskupinami a spôsob jeho výroby

Country Status (6)

Country Link
CZ (1) CZ301047B6 (cs)
PL (1) PL196485B1 (cs)
RU (1) RU2288705C2 (cs)
SK (1) SK287298B6 (cs)
UA (1) UA75072C2 (cs)
WO (1) WO2001085176A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1004331B (el) * 2002-10-07 2003-09-05 Verisfield (Uk) Ltd Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
AU2004275569B2 (en) * 2003-09-29 2011-04-21 Cipla Limited Pharmaceutical formulation with improved stability
WO2006046100A1 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Pharmaceutical composition of alendronic acid
GB0616794D0 (en) 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
WO2009018834A1 (en) * 2007-08-06 2009-02-12 Pharmathen S.A. Pharmaceutical composition containing bisphosphonate and method for the preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
FI89364C (fi) * 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya, farmakologiskt anvaendbara metylenbisfosfonsyraderivat
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
KR100266484B1 (ko) * 1992-05-29 2000-09-15 제이코버스 코넬리스 레이서 칼슘및인산염의이상대사를치료하기위한티오-치환된질소-함유헤테로사이클릭포스포네이트화합물
EP0642519B1 (en) * 1992-05-29 2000-08-09 Procter & Gamble Pharmaceuticals Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
WO2000038660A2 (de) * 1998-12-23 2000-07-06 Jomaa Pharmaka Gmbh Verwendung von bisphosphonaten zur prophylaxe und zur behandlung von infektiösen prozessen
CZ20004762A3 (cs) * 1999-06-24 2001-04-11 Hassan Jomaa Bisfosfonové kyseliny a jejich deriváty obsahující léčiva pro profylaxi a ošetřování autoimunitních chorob i alergií

Also Published As

Publication number Publication date
UA75072C2 (en) 2006-03-15
CZ20023700A3 (cs) 2003-04-16
CZ301047B6 (cs) 2009-10-21
WO2001085176A1 (en) 2001-11-15
PL196485B1 (pl) 2008-01-31
SK15842002A3 (sk) 2003-03-04
PL340087A1 (en) 2001-11-19
RU2288705C2 (ru) 2006-12-10

Similar Documents

Publication Publication Date Title
KR100496086B1 (ko) 비스포스포네이트를 포함하는 경구 투여용 약학 조성물의 제조 방법
FI109088B (fi) Tabletti ja menetelmä sen valmistamiseksi
KR20010086062A (ko) 고가용성 약물용 서방성 메트리스 시스템
KR20100015764A (ko) 프레가발린을 포함하는 안정한 약학적 조성물
JP2010083900A (ja) レボシメンダンの制御放出経口用組成物
SK283249B6 (sk) Tableta vyrobiteľná priamym tabletovaním, obsahujúca aktívnu látku kyselinu 4-amino-1-hydroxybutylidén-1,1-bisfosfónovú a spôsob jej výroby
EP1648451A2 (en) Fluconazole capsules with improved release
SK287298B6 (sk) Tuhý perorálny farmaceutický prostriedok vo forme tabliet s obsahom derivátu kyseliny bifosfónovej substituovaného aminoskupinami a spôsob jeho výroby
EP2934494B1 (en) Pharmaceutical formulation of n- [5- [2-(3,5-dimethoxyphenyl) ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide
US20040126422A1 (en) Novel co-processing method for oral drug delivery
SK2132002A3 (en) Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof
CN115212176B (zh) 泽布替尼缓释片剂
RU2810575C1 (ru) Фармацевтическая композиция, включающая мемантин и цитиколин, а также лекарственная форма на основе указанной фармацевтической композиции, включающей мемантин и цитиколин, способ ее получения и применение лекарственной формы на основе фармацевтической композиции, включающей мемантин и цитиколин
KR101953294B1 (ko) 오셀타미비어 함유 경구용 고형제제 및 그 제조방법
TR2023018145A2 (tr) Geli̇şti̇ri̇lmi̇ş çözünme hizina sahi̇p mi̇kofenolat mofeti̇l fi̇lm kapli tablet formülasyonlari i̇çi̇n üreti̇m yöntemi̇
US20060177512A1 (en) Process for preparing formulations of lipid-regulating drugs
MX2007014056A (es) Composicion farmaceutica solida para administracion oral de acido ibandronico o una sal o un hidrato farmaceuticamente aceptable del mismo, procedimiento de preparacion de dicha composicion mediante compresion directa, formulaciones farmaceuticas que
SK15612000A3 (sk) Perorálne tablety s riadeným uvoľňovaním farmaceuticky akceptovateľných solí metoprololu a spôsob ich prípravy
HRP20020153A2 (en) Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof
HK1212229B (en) Pharmaceutical formulation of n- [5- [2-(3,5-dimethoxyphenyl) ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide
CS267602B1 (cs) Způsob výroby stabilního přípravku s obsahem chlordiazepoxidu
SK2262003A3 (sk) Perorálny liečivý prípravok s riadeným uvoľňovaním bupropion hydrochloridu a spôsob jeho prípravy

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100412